VICENTE
FURIÓ BACETE
Investigador hasta 2010
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (8)
2014
-
18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: Association of loco-regional SUVmax with classical prognostic factors
Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 58, Núm. 1, pp. 66-73
-
Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection
Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394
2013
-
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
Annals of Oncology, Vol. 24, Núm. 3, pp. 655-661
-
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Breast Cancer Research and Treatment, Vol. 138, Núm. 2, pp. 457-466
2012
-
Glutathione S-transferase P1 c.313a > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients
Annals of Oncology, Vol. 23, Núm. 7, pp. 1750-1756
-
Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Annals of Oncology, Vol. 23, Núm. 3, pp. 625-631
2011
-
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136
2004
-
Estudio histológico, morfométrico y ultraestructural de la placenta en diabéticas e hipertensas gestacionales con buen control terapéutico
Acta Ginecologica, Vol. 61, Núm. 5, pp. 146-153